ResearcherYamaguchi UniversityActive in the last 2 years

Gen Kanesada

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-7578-7577; OpenAlex author ID A5117329273. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2025: 1 paper

Papers 1

The C11orf24 Gene as a Useful Biomarker for Predicting Severe Neutropenia in Modified FOLFIRINOX for Pancreatic Cancer. Co-author DOI 10.1111/cas.70087 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yoshitaro Shindo · 1 shared paper, 2025 · strength 0.25
- Paper The C11orf24 Gene as a Useful Biomarker for Predicting Severe Neutropenia in Modified FOLFIRINOX for Pancreatic Cancer. DOI 10.1111/cas.70087 ↗
Tatsuya Ioka · 1 shared paper, 2025 · strength 0.25
- Paper The C11orf24 Gene as a Useful Biomarker for Predicting Severe Neutropenia in Modified FOLFIRINOX for Pancreatic Cancer. DOI 10.1111/cas.70087 ↗
Hirofumi Akita · 1 shared paper, 2025 · strength 0.25
- Paper The C11orf24 Gene as a Useful Biomarker for Predicting Severe Neutropenia in Modified FOLFIRINOX for Pancreatic Cancer. DOI 10.1111/cas.70087 ↗
Hiroaki Nagano · 1 shared paper, 2025 · strength 0.25
- Paper The C11orf24 Gene as a Useful Biomarker for Predicting Severe Neutropenia in Modified FOLFIRINOX for Pancreatic Cancer. DOI 10.1111/cas.70087 ↗
Hiroto Matsui Matsui · 1 shared paper, 2025 · strength 0.25
- Paper The C11orf24 Gene as a Useful Biomarker for Predicting Severe Neutropenia in Modified FOLFIRINOX for Pancreatic Cancer. DOI 10.1111/cas.70087 ↗
Ryouichi Tsunedomi · 1 shared paper, 2025 · strength 0.25
- Paper The C11orf24 Gene as a Useful Biomarker for Predicting Severe Neutropenia in Modified FOLFIRINOX for Pancreatic Cancer. DOI 10.1111/cas.70087 ↗
Hidenori Takahashi · 1 shared paper, 2025 · strength 0.25
- Paper The C11orf24 Gene as a Useful Biomarker for Predicting Severe Neutropenia in Modified FOLFIRINOX for Pancreatic Cancer. DOI 10.1111/cas.70087 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.